This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kevin Brennan: Innovator in Chromatography Performance Monitoring
Introduction
Kevin Brennan is a notable inventor based in Menands, NY (US). He has made significant contributions to the field of chromatography through his innovative patent. His work focuses on enhancing the performance monitoring of chromatography systems, which is crucial for various applications in scientific research and industry.
Latest Patents
Kevin Brennan holds a patent titled "Ultraviolet monitoring of chromatography performance by orthogonal partial least squares." This patent discloses methods for monitoring column chromatography performance. The methods include acquiring one or more chromatogram ultraviolet (UV) traces generated by a chromatography system during sample purification and/or separation. Additionally, it involves analyzing the acquired chromatogram UV traces with an orthogonal partial least squares (OPLS) model. This innovative approach allows for the detection of column deterioration prior to failure and enables quantitative analysis of the UV signal in the chromatogram UV traces.
Career Highlights
Kevin Brennan is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in chromatography and analytical methods. His work at Regeneron contributes to the advancement of biopharmaceutical research and development. With a focus on improving analytical techniques, he plays a vital role in ensuring the quality and reliability of chromatography processes.
Collaborations
Kevin collaborates with talented professionals in his field, including Eric Shierly and Nathan L. Mao. These collaborations enhance the innovative environment at Regeneron Pharmaceuticals and contribute to the development of cutting-edge technologies in chromatography.
Conclusion
Kevin Brennan's contributions to chromatography performance monitoring through his patent demonstrate his commitment to innovation in the field. His work not only advances scientific research but also supports the pharmaceutical industry in ensuring high-quality analytical processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile